The historical rank and industry rank for Fortrea Holdings's FCF Margin % or its related term are showing as below:
MEX:FTRE1'
s FCF Margin % Range Over the Past 10 Years
Min: 1 Med: 4.6 Max: 8.8
Current: 7.03
During the past 6 years, the highest FCF Margin % of Fortrea Holdings was 8.80%. The lowest was 1.00%. And the median was 4.60%.
MEX:FTRE1's FCF Margin % is ranked better than 80.4% of 959
companies
in the Biotechnology industry
Industry Median: -84.65
vs MEX:FTRE1: 7.03
Fortrea Holdings FCF Margin % Related Terms
Fortrea Holdings FCF Margin % Historical Data
* Premium members only.
The historical data trend for Fortrea Holdings's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:FTRE1 vs MAZE, KALV, BCAX: FCF Margin % Comparison
For the Biotechnology subindustry, Fortrea Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fortrea Holdings FCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Fortrea Holdings's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Fortrea Holdings's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fortrea Holdings (MEX:FTRE1) has a FCF Margin % of -3.93% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Fortrea Holdings and its competitors. Over the past decade, Fortrea Holdings' FCF Margin % has ranged from 1.00 to 8.80. According to the industry distribution chart, Fortrea Holdings ranks #188 out of 959 companies in the Biotechnology industry, placing it in the top 19.6%.
Is Fortrea Holdings' FCF Margin % too high?
Fortrea Holdings' current FCF Margin % is -3.93%. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 8.80. Based on the distribution chart, Fortrea Holdings ranks #188 out of 959 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Fortrea Holdings has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Fortrea Holdings' FCF Margin % compare to MAZE and KALV?
According to the Biotechnology industry distribution chart, Fortrea Holdings ranks #188 out of 959 companies for FCF Margin %. This places Fortrea Holdings in the top 20% of its industry — outperforming the majority of peers. Historically, Fortrea Holdings' own FCF Margin % has ranged from 1.00 to 8.80 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Fortrea Holdings and its competitors. Fortrea Holdings's current FCF Margin % is -3.93%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortrea Holdings stock overvalued right now?
Fortrea Holdings (MEX:FTRE1) has a current FCF Margin % of -3.93%. The stock's GF Value™ is MXN448.82, compared to a current price of MXN435.30 — trading 3% below its estimated fair value. The current FCF Margin % is -3.93%. Fortrea Holdings' overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Fortrea Holdings (MEX:FTRE1), the current FCF Margin % is -3.93% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fortrea Holdings (MEX:FTRE1) Overvalued in 2026?
Based on GuruFocus' analysis, Fortrea Holdings stock appears to be undervalued.
The current stock price of MXN435.30 is trading 3% below its estimated GF Value™ of MXN448.82.
Key valuation signals for MEX:FTRE1:
FCF Margin %: -3.93%
GF Value™: MXN448.82 vs. price of MXN435.30 (3% below fair value)
No single metric tells the full story. See the MEX:FTRE1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
66GF Score
Get the complete analysis for MEX:FTRE1
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:FTRE1 has been successfully added to your 
